BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23812769)

  • 1. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer.
    Alvarado MD; Mohan AJ; Esserman LJ; Park CC; Harrison BL; Howe RJ; Thorsen C; Ozanne EM
    Ann Surg Oncol; 2013 Sep; 20(9):2873-80. PubMed ID: 23812769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.
    Vaidya A; Vaidya P; Both B; Brew-Graves C; Bulsara M; Vaidya JS
    BMJ Open; 2017 Aug; 7(8):e014944. PubMed ID: 28819067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option?
    Shah C; Badiyan S; Khwaja S; Shah H; Chitalia A; Nanavati A; Kundu N; Vaka V; Lanni TB; Vicini FA
    Clin Breast Cancer; 2014 Apr; 14(2):141-6. PubMed ID: 24291378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
    Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of intraoperative radiation therapy versus external beam radiation therapy for the adjuvant treatment of early breast cancer: A systematic review.
    Eisavi M; Rezapour A; Alipour V; Mirzaei HR; Arabloo J
    Med J Islam Repub Iran; 2020; 34():167. PubMed ID: 33816366
    [No Abstract]   [Full Text] [Related]  

  • 6. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
    Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
    Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays.
    Welzel G; Hofmann F; Blank E; Kraus-Tiefenbacher U; Hermann B; Sütterlin M; Wenz F
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():359-67. PubMed ID: 20853059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.
    Sher DJ; Wittenberg E; Suh WW; Taghian AG; Punglia RS
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):440-6. PubMed ID: 18963542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer.
    Hayman JA; Hillner BE; Harris JR; Weeks JC
    J Clin Oncol; 1998 Mar; 16(3):1022-9. PubMed ID: 9508186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Schoeber C; Schaefer J; Steil V; Wenz F
    BMC Cancer; 2007 Sep; 7():178. PubMed ID: 17854511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime cost-effectiveness analysis of intraoperative radiation therapy versus external beam radiation therapy for early stage breast cancer.
    Patel R; Ivanov O; Voigt J
    Cost Eff Resour Alloc; 2017; 15():22. PubMed ID: 29151818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
    Suh WW; Hillner BE; Pierce LJ; Hayman JA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1054-61. PubMed ID: 15752884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer.
    Hayman JA; Hillner BE; Harris JR; Pierce LJ; Weeks JC
    J Clin Oncol; 2000 Jan; 18(2):287-95. PubMed ID: 10637242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients.
    Lee JH; Glick HA; Hayman JA; Solin LJ
    J Clin Oncol; 2002 Jun; 20(11):2713-25. PubMed ID: 12039934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of intraoperative radiation therapy versus intensity-modulated radiation therapy for the treatment of early breast cancer: a disinvestment analysis.
    Muñoz-Montecinos C; González-Browne C; Maza F; Carreño-Leiton D; González P; Chahuan B; Quirland C
    BMC Health Serv Res; 2024 Apr; 24(1):417. PubMed ID: 38570764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.
    Liberato NL; Marchetti M; Barosi G
    J Clin Oncol; 2007 Feb; 25(6):625-33. PubMed ID: 17308267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?
    Esserman LJ; Alvarado MD; Howe RJ; Mohan AJ; Harrison B; Park C; O'Donoghue C; Ozanne EM
    Breast Cancer Res Treat; 2014 Apr; 144(2):371-8. PubMed ID: 24584875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.